O31. An Open Label, Pilot, Multi-Centre, Step-Down, Randomized Controlled Trial to Examine Whether Etanercept 25 mg Once Weekly is Effective in Maintaining a Clinical Response in Patients with Ankylosing Spondylitis who have Responded to 50 mg Once Weekly
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.